Haskap for Digestion
(PHMTiming Trial)
Trial Summary
What is the purpose of this trial?
Diet is a key factor in managing health and individuals at risk of developing metabolic syndrome or other chronic diseases have the opportunity to use diet as a tool to improve their health. This can be complicated when considering the numerous variables that impact digestion and absorption of key health-promoting compounds in foods. One of these variables is the gut microbiome, a microbial community in the digestive tract that interacts with the foods we consume. The mechanisms the microbiome uses to interact with bioactive compounds in foods, like polyphenols, can modulate the health-promoting benefits of polyphenols. Polyphenols are secondary plant metabolites, commonly found in fruit, legumes, chocolate, coffee, and nuts among other foods that have been shown to improve cardiovascular and metabolic health, as well as reduce inflammation and oxidative stress.
Will I have to stop taking my current medications?
If you take medication to lower cholesterol, inflammation, or lipids, you will need to stop taking them to participate in this trial.
Research Team
Mary P Miles, PhD
Principal Investigator
Montana State University
Eligibility Criteria
This trial is for individuals at risk of metabolic syndrome or other chronic diseases, who are interested in using diet to improve their health. It focuses on how the gut microbiome interacts with polyphenols from foods like fruit and nuts.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants consume Haskap puree after a fasting blood sample is collected
Follow-up
Participants are monitored for metabolite identity and abundance after Haskap consumption
Treatment Details
Interventions
- Haskap
Find a Clinic Near You
Who Is Running the Clinical Trial?
Montana State University
Lead Sponsor